About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Quant Consumption Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesReliance Industries Limited10.385220947629.4314
Domestic EquitiesMarico Limited8.658134536924.5367
Domestic EquitiesAditya Birla Fashion And Retail Ltd8.226588459923.3136
Domestic EquitiesVentive Hospitality Limited7.760130595121.9918
Domestic EquitiesZydus Wellness Ltd7.084411373720.0769
Domestic EquitiesBata India Ltd6.756515845519.1477
Domestic EquitiesMRF Ltd6.7443142119.1132
Domestic EquitiesStanley Lifestyles Limited5.062546954314.3469
Domestic EquitiesUNITED BREWERIES LIMITED4.94456487314.0126
Domestic EquitiesSuraksha Diagnostic Limited4.533042936212.8465
Domestic EquitiesJio Financial Services Limited4.116544796911.6660
Domestic EquitiesProcter & Gamble Hygiene & Health Care Limited2.878857288.1584
Domestic EquitiesAurobindo Pharma Limited2.5290583127.1671
Domestic EquitiesEmami Limited2.42081098196.8604
Total 82.1001 232.6692
Cash & Cash Equivalents and Net AssetsTREPS 02-May-2025 DEPO 1011.62013293732.9311
Cash & Cash Equivalents and Net AssetsNCA-NET CURRENT ASSETS-13.3564 -37.8516
Total -1.7363 -4.9205
Treasury Bills91 Days Treasury Bill 12-Jun-20252.80408000007.9464
Treasury Bills91 Days Treasury Bill 30-May-20251.75625000004.9770
Treasury Bills91 Days Treasury Bill 19-Jun-20251.05033000002.9765
Treasury Bills91 Days Treasury Bill 05-Jun-20250.70182000001.9888
Treasury Bills91 Days Treasury Bill 17-Jul-20250.69702000001.9754
Total 7.0093 19.8641
Derivatives-FuturesColgate-Palmolive (India) Ltd 29/05/20258.57789450024.3092
Derivatives-FuturesTata Consumer Products Ltd 29/05/20253.0917752408.7617
Derivatives-FuturesAurobindo Pharma Limited 29/05/20250.9574220002.7133
Total 12.6269 35.7842
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.